Clinical Trial Update: Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating irinotecan followed by radiation therapy and temozolomide in children with newly diagnosed brain tumors; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors
• Central Nervous System Neoplasms

Drugs mentioned

• Camptosar (irinotecan)
• Temodar (Temozolomide)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED